Aktie 4171 GENEREACH BIOTECHNOLOGY CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen GeneReach Biotechnology Corp.

Aktien

4171

TW0004171004

4171

Schlusskurs Taipei Exchange
Andere Börsenplätze
 00:00:00 10.05.2024 		% 5 Tage % 1. Jan.
32,05 TWD -0,93 % Intraday Chart für GeneReach Biotechnology Corp. -1,38 % -18,76 %
28.03. GeneReach Biotechnology Corp. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 GeneReach Biotechnology Corp. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
GeneReach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
GeneReach Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
GeneReach Biotechnology Corp.(TPEX:4171) dropped from S&P Global BMI Index
GeneReach Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
GeneReach Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
GeneReach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
GeneReach Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
GeneReach Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
GeneReach Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
GeneReach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2021
Taiwan's OBI Pharma Grants Experimental Drug Rights to Odeon Therapeutics (Hong Kong)
GeneReach Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Genereach Biotechnology Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021
Genereach Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021
Genereach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2020
Genereach Biotechnology Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2020
GeneReach Biotechnology Corp.(GTSM:4171) added to S&P Global BMI Index
Genereach Biotechnology Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2020
Genereach Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2020
Genereach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2019
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 4171 Aktie
  4. Nachrichten GeneReach Biotechnology Corp.
  5. Andere Sprachen